CIBC Asset Management
RGC icon

CIBC Asset Management’s Regencell Bioscience RGC Stock Holding History

CIBC Asset Management’s Portfolio RGC Stock Details RGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$93.1K Buy
+15,292
New +$367K ﹤0.01% 1384

Other funds holding RGC

FRM
Fox Run Management Greenwich, Connecticut $603M AUM 32% 1-Year Est. Return
SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
BFS
Bare Financial Services Gap, Pennsylvania $436M AUM 20.22% 1-Year Est. Return

CIBC Asset Management's RGC Position: Q2 2026 in Review

CIBC Asset Management opened a new position in Regencell Bioscience (RGC) in Q2 2026: 15,292 shares worth $93.1K. The stake represents ﹤0.01% of the portfolio and ranks #1384 among its holdings.

8 funds tracked by Wall St. Rank hold RGC as of Q2 2026.

  • CIBC Asset Management held 15,292 shares of Regencell Bioscience worth $93.1K as of Q2 2026.
  • Regencell Bioscience was a new CIBC Asset Management position in Q2 2026.
  • Regencell Bioscience made up ﹤0.01% of CIBC Asset Management's portfolio in Q2 2026, its #1384 holding.
  • 8 funds tracked by Wall St. Rank held Regencell Bioscience as of Q2 2026.

Based on CIBC Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.